Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > New autoimmune research charity joins the Connect Immune Research partnership
Juvenile Arthritis Research, a charity focused on the autoimmune condition juvenile idiopathic arthritis (JIA), becomes the 12th member of the Connect Immune Research partnership.
Established in 2018, Connect Immune Research is a collaborative initiative that aims to unpick the root causes of autoimmunity, where the immune system mistakenly attacks our own healthy cells. The partnership enables scientists to think beyond individual autoimmune conditions and explore overlapping causes of autoimmunity. This tactic boosts our potential of developing new treatments for a range of conditions including type 1 diabetes, multiple sclerosis and arthritis.
JIA is a rheumatic condition – meaning chronic joint pain – that begins before children are 16 years old. It happens when the immune system attacks and damages the joints, resulting in pain and mobility issues. Although JIA begins in childhood and adolescence, it is a lifelong condition. We have immune therapies that can target the symptoms of JIA, but not the underlying causes. Juvenile Arthritis Research is a parent-led charity committed to finding a cure for JIA.
Richard Beesley, Founder of Juvenile Arthritis Research, said: “When I first founded Juvenile Arthritis Research five years ago it was with the expectation that some of the clues to better understanding Juvenile Idiopathic Arthritis, and some of the knowledge to develop better treatments, would be by working closely with other autoimmune disease areas. That’s why I am delighted that we are joining the Connect Immune Research partnership, with the aim to continue to transform lives through working with others, sharing knowledge and ideas, and making a better future for the children, young people, adults and families we support.”
Dr Caroline Schmutz, Head of Research Partnerships at JDRF UK, said: “We are excited to welcome Juvenile Arthritis Research as our newest Connect Immune Research member. Their collaborative approach to research and confidence in the benefits of combining research across different disease areas make Juvenile Arthritis Research an ideal partner. The more research organisations we have studying the biological mechanisms driving autoimmunity, the sooner we will develop new treatments and cures for multiple autoimmune conditions.”
Find out more about our Connect Immune Research partnership.
Learn about British Thyroid Foundation (BTF) joining Connect Immune Research.
Learn about Professor Lucy Walker's research project, funded through Connect Immune Research.
If you use the Dexcom G6 app on your Android smartphone, the newest Android 16 operating system may disrupt how the app functions.
We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.
Breakthrough T1D has helped organise an event hosted by Tomislav Sokol titled ‘Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes.’
People living with type 1 diabetes (T1D) across the UK now have more choice in how to manage their condition, with the mylife CamAPS FX app now available on iPhones.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
